ZA931100B - A 90K tumor-associated antigen, IR-95. - Google Patents
A 90K tumor-associated antigen, IR-95.Info
- Publication number
- ZA931100B ZA931100B ZA931100A ZA931100A ZA931100B ZA 931100 B ZA931100 B ZA 931100B ZA 931100 A ZA931100 A ZA 931100A ZA 931100 A ZA931100 A ZA 931100A ZA 931100 B ZA931100 B ZA 931100B
- Authority
- ZA
- South Africa
- Prior art keywords
- tumor
- associated antigen
- antigen
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3015—Breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM920099A IT1264490B (it) | 1992-02-17 | 1992-02-17 | Antigene 90k associato a tumori. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA931100B true ZA931100B (en) | 1994-08-17 |
Family
ID=11400690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA931100A ZA931100B (en) | 1992-02-17 | 1993-02-17 | A 90K tumor-associated antigen, IR-95. |
Country Status (6)
Country | Link |
---|---|
CN (1) | CN1076629A (xx) |
AU (2) | AU3629093A (xx) |
IL (1) | IL104745A0 (xx) |
IT (1) | IT1264490B (xx) |
WO (2) | WO1993017119A2 (xx) |
ZA (1) | ZA931100B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2175922A1 (en) * | 1993-11-05 | 1995-05-11 | Stefano Iacobelli | Methods relating to ir-95 |
CN1313603C (zh) * | 2004-09-30 | 2007-05-02 | 北京大学人民医院 | 抗人卵巢癌单克隆抗体杂交瘤细胞系及其单克隆抗体和应用 |
GB2435882A (en) * | 2006-03-09 | 2007-09-12 | Bioinvent Int Ab | Detection and treatment of mantle cell lymphoma |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL76877A (en) * | 1984-11-02 | 1991-11-21 | Oncogen | Diagnostic method for the determination of human non-small cell lung carcinomas employing novel monoclonal antibodies and compositions containing said antibodies |
IT1239719B (it) * | 1990-04-23 | 1993-11-15 | Univ Degli Studi Annunzio | Uso dell'anticorpo monoclonale sp-2 nella diagnostica clinica ed il monitoraggio del progredire dell'infezione hiv |
-
1992
- 1992-02-17 IT ITRM920099A patent/IT1264490B/it active IP Right Grant
-
1993
- 1993-02-16 IL IL104745A patent/IL104745A0/xx unknown
- 1993-02-16 AU AU36290/93A patent/AU3629093A/en not_active Withdrawn
- 1993-02-16 WO PCT/EP1993/000379 patent/WO1993017119A2/en not_active Application Discontinuation
- 1993-02-17 AU AU34979/93A patent/AU3497993A/en not_active Abandoned
- 1993-02-17 CN CN93101808A patent/CN1076629A/zh active Pending
- 1993-02-17 WO PCT/EP1993/000385 patent/WO1993016181A1/en active Application Filing
- 1993-02-17 ZA ZA931100A patent/ZA931100B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU3629093A (en) | 1993-09-13 |
WO1993016181A1 (en) | 1993-08-19 |
CN1076629A (zh) | 1993-09-29 |
ITRM920099A1 (it) | 1993-08-18 |
AU3497993A (en) | 1993-09-03 |
IL104745A0 (en) | 1993-06-10 |
WO1993017119A2 (en) | 1993-09-02 |
IT1264490B (it) | 1996-09-24 |
ITRM920099A0 (it) | 1992-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0627932A4 (en) | NEW ANTIBODY STRUCTURE. | |
EP0656628A3 (en) | Programmed reference. | |
AR244082A1 (es) | Composiciones de champu | |
EP0580285A3 (en) | Auto-reclosers. | |
ZA939450B (en) | A comb. | |
EP0703659A4 (en) | AC POWERED ELECTRODYNAMIC DEVICE WITH SEVERAL ROTORS | |
ZA926733B (en) | 1,2-Dihydro-2-oxopyridines. | |
EP0676966A4 (en) | Antibodies directed against binding associated epitopes. | |
ZA931232B (en) | A joining device. | |
EP0640758A3 (en) | Charge dosing device. | |
EP0649734A3 (en) | Packaging. | |
EP0640757A3 (en) | Load metering device. | |
EP0652630A3 (en) | Semiconductor stack. | |
EP0644636A3 (en) | Wavelength conversion device. | |
GB2272220B (en) | a,w-alkanediphenols | |
EP0609522A3 (de) | Verpackung. | |
ZA937127B (en) | Catch. | |
AU3497893A (en) | Sequences for a 90K tumor-associated antigen, immunoregulin-95 (IR-95) | |
EP0603840A3 (de) | Schwenklager. | |
EP0571983A3 (en) | Macromonomeric compounds terminated in alpha, omega with methacrylate. | |
ZA931100B (en) | A 90K tumor-associated antigen, IR-95. | |
EP0671665A3 (en) | Sorter. | |
EP0634841A3 (en) | Smooth spectrum spread with a small spreading factor. | |
EP0624089A4 (en) | Methods. | |
ZA93432B (en) | Improved packaging element. |